Clozapine-induced neuroleptic malignant syndrome: an interaction between dopaminergic and purinergic systems?

Abstract

Get full access to this article

View all access options for this article.

References

Amore M , Zazzeri N , Berardi D (1997) Atypical neuroleptic malignant syndrome associated with clozapine treatment. Neuropsychobiology 35: 197-199

Fuxe K , Ferre S , Zoli M , Agnati L F (1998) Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia. Brain Res Brain Res Rev 26: 258-273

Kalkman HO , Neumann V , Hoyer D , Tricklebank M D (1998) The role of alpha2-adrenoceptor antagonism in the anti-cataleptic properties of the atypical neuroleptic agent, clozapine, in the rat. Br J Pharmacol 124: 1550-1556

Kapur S (1998) A new framework for investigating antipsychotic action in humans: lessons from PET imaging. Mol Psychiatry 3: 135-140

Keck PE Jr , Caro¡ S N , McElroy S (1995) Neuroleptic malignant syndrome and malignant hyperthermia: end of a controversy? J Neuropsychiatry Clin Neurosci 7: 135-144

Lara D R , Souza D O (1999) Schizophrenia: a purinergic hypothesis. Med Hypotheses in press

Parsons B , Togasaki DM , Kassir S , Przedborski S (1995) Neuroleptics up-regulate adenosine A2a receptors in rat striatum: implications for the mechanism and the treatment of tardive dyskinesia. J Neurochem 65: 2057-2064

Pinna A , Wardas J , Cozzolino A , Morelli M (1999) Involvement of adenosine A2A receptors in the induction of C-Fos expression by clozapine and haloperidol. Neuropsychopharmacology 20: 44-51

Richelson E , Nelson A (1984) Antagonism by neuroleptics of neuro-transmitter receptors of normal human brain in vitro. Eur J Pharmacol 103: 197-204

10.

Sachedev P , Kruk J , Kneebone M , Kissane D (1995) Clozapineinduced neuroleptic malignant syndrome: review and report of new cases. J Clin Psychopharmacol 15: 365-371

11.

Seeman P , Tallerico T (1998) Atypical antipsychotics which elicit little or no Parkinson bind more loosely to D2 receptors, yet occupy high levels of these receptors. Mol Psychiatry 3: 123-134

12.

Tsai G , Crisostomo G , Rosenblatt M L , Stern TA (1995) Neuroleptic malignant syndrome associated with clozapine treatment. Ann Clin Psychiatry 7: 91-95